載入...
Use of hemodialysis for the treatment of intracerebral hemorrhage in patients on dabigatran with normal renal function
Dabigatran is a direct thrombin inhibitor which is approved by the Food and Drug Administration (FDA) for prevention of embolic stroke in patients with atrial fibrillation. Dabigatran has been shown to be non- inferior to warfarin in preventing stroke in patients with atrial fibrillation [1, 6]. The...
Na minha lista:
| 發表在: | Clin Nephrol Case Stud |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Dustri-Verlag Dr. Karl Feistle
2014
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5437993/ https://ncbi.nlm.nih.gov/pubmed/29043124 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5414/CNCS108253 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|